Smartlab Europe

Tag: Biopharma Businesses

Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal

Sanofi has committed up to $1.53 billion to obtain global rights to a novel therapy from Sino Biopharmaceutical, adding a first-in-class JAK/ROCK inhibitor to...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to head deeper into the KRAS space by way of securing the right when it comes...

Bora – Corealis Collaborate for Oral Solid Dose Development

Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization...

Eli Lilly & IU Join Hands to Expand Clinical Trials Access

A new agreement as per which Eli Lilly and Company is going to offer almost $40 million to Indiana University - IU has come...

IQVIA Agentic AI Platform Builds New Capabilities with AWS

IQVIA, known across the life sciences industry for its clinical research operations, commercial analytics, and health-data expertise, has entered a strategic collaboration with Amazon...

Trump To Exempt UK-Origin Pharmaceuticals from Tariffs

The Trump administration has lined up yet another country-specific trade agreement, and this time it is going to be with the U.K., which confers...

Azerbaijan, Jordan Explore Joint Pharmaceutical Venture

Azerbaijan and Jordan are looking out for new opportunities in order to establish a joint pharmaceutical venture, thereby signalling a very robust step towards...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »